- Home
- BKYI vs RSLS Comparison
BKYI vs RSLS Comparison
Compare BKYI & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- RSLS
- Stock Information
- Founded
- BKYI 1993
- RSLS 2002
- Country
- BKYI United States
- RSLS United States
- Employees
- BKYI N/A
- RSLS N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- RSLS Medical/Dental Instruments
- Sector
- BKYI Technology
- RSLS Health Care
- Exchange
- BKYI Nasdaq
- RSLS Nasdaq
- Market Cap
- BKYI 3.8M
- RSLS 3.2M
- IPO Year
- BKYI 1997
- RSLS 2007
- Fundamental
- Price
- BKYI $0.75
- RSLS $0.45
- Analyst Decision
- BKYI
- RSLS Hold
- Analyst Count
- BKYI 0
- RSLS 1
- Target Price
- BKYI N/A
- RSLS N/A
- AVG Volume (30 Days)
- BKYI 391.9K
- RSLS 16.2M
- Earning Date
- BKYI 03-27-2025
- RSLS 05-14-2025
- Dividend Yield
- BKYI N/A
- RSLS N/A
- EPS Growth
- BKYI N/A
- RSLS N/A
- EPS
- BKYI N/A
- RSLS N/A
- Revenue
- BKYI $6,929,571.00
- RSLS $8,183,000.00
- Revenue This Year
- BKYI $1.96
- RSLS $17.47
- Revenue Next Year
- BKYI $9.65
- RSLS $20.00
- P/E Ratio
- BKYI N/A
- RSLS N/A
- Revenue Growth
- BKYI N/A
- RSLS N/A
- 52 Week Low
- BKYI $0.52
- RSLS $0.34
- 52 Week High
- BKYI $3.68
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- BKYI 30.45
- RSLS 40.85
- Support Level
- BKYI $0.75
- RSLS $0.34
- Resistance Level
- BKYI $1.20
- RSLS $3.05
- Average True Range (ATR)
- BKYI 0.11
- RSLS 0.24
- MACD
- BKYI -0.03
- RSLS 0.11
- Stochastic Oscillator
- BKYI 7.92
- RSLS 3.92
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.